Photodynamic Therapy Using Porfimer Sodium in Treating Patients with Recurrent Mouth or Throat Dysplasia or Recurrent in situ Cancer or Stage I Cancer of the Mouth or Throat

December 23, 2009

This trial will evaluate how well photodynamic therapy using porfimer sodium works in treating patients with recurrent mouth or throat dysplasia, recurrent in situ cancer of the mouth or throat, or stage I cancer of the mouth or throat.

Study Type: Interventional

Age/Sex Requirement: 18 years+ (None)

Sponsor: Roswell Park Cancer Institute

Clinicaltrials.gov Identifier: NCT00530088

Purpose: To study how well photodynamic therapy using porfimer sodium works in treating patients with recurrent mouth or throat dysplasia, recurrent in situ cancer of the mouth or throat, or stage I cancer of the mouth or throat. Primary outcomes measures include response and local toxicity.

Click here to access additional information from this third-party website.